Study on Violence Against Vulnerable Women and Optimizing Support Services (ENVVOL)
A Study in Nîmes on Violence Against Vulnerable Women and Optimizing Support Services
연구 개요
상세 설명
Gender-based and sexual violence in France primarily affects women, who account for 88% of victims. Each year, around 670,000 women experience this violence, including 213,000 at the hands of their current or former partner. Among them, 94,000 are victims of rape or attempted rape-that's one rape every 8 minutes. This violence particularly affects minors, with 59% of men accused of having victims under the age of 18. Yet only 1 in 5 victims files a complaint. In 2023, 134 women were killed by their spouse or former spouse. In addition to the direct victims, the children in the family are often co-victims, exposed to violence and suffering from serious psychological and behavioral consequences. In 2024, more than 450,000 victims of physical violence and 122,600 victims of sexual violence were recorded, a situation that is particularly alarming among women in vulnerable situations (minors, migrants, and the homeless). Some migrant women undergo female genital mutilation, resulting in lasting trauma. In 2010, the number of adult women who had undergone female genital mutilation (FGM) in France was estimated at more than 124,000. Violence has serious impacts on physical and mental health: post-traumatic stress, sleep disorders, depression, risky behaviors, as well as an increased incidence of certain diseases (cardiovascular diseases, cancers, gynecological conditions). Pregnancy is often an aggravating factor in domestic violence, with increased risks for both the mother and the child. Children exposed to domestic violence also suffer from various problems (developmental delays, behavioral disorders, and impaired self-esteem). On average, 3 femicides per day are recorded, whether direct or indirect.
Despite increased use of emergency rooms, medical follow-up for victims remains inconsistent. According to the WHO, this violence reduces women's healthy life expectancy by 1 to 4 years. Beyond individual suffering, this violence carries a heavy social and economic cost, affecting professional life, the ability to care for themselves and their children, and often leading to isolation. The main aim of this study is to assess improvements in quality of life at 6 months (baseline vs. 6-month comparison) following multidisciplinary care for vulnerable women or victims of violence referred to a specialized facility such as the Maison Des Femmes (MDF).
연구 유형
등록 (추정된)
연락처 및 위치
연구 연락처
- 이름: Sylvie RIPART, Dr.
- 전화번호: +336.87.70.13.02
- 이메일: sylvie.ripart@chu-nimes.fr
연구 연락처 백업
- 이름: Clémence CASARA, Midwife
- 전화번호: +334.66.68.67.52
- 이메일: clemence.casara@chu-nimes.fr
참여기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
샘플링 방법
연구 인구
설명
Inclusion criteria :
- Adult women receiving care at the MDF in the Gard department;
- Women in situations of vulnerability and violence
- Women who agree to participate in the study and have signed the consent form;
- Non-French-speaking women who can be assisted in understanding through the midwife's intervention and telephone interpretation
Note: Pregnant and breastfeeding women may be included. Indeed, pregnancy is a trigger or aggravating factor for domestic violence and can further exacerbate the precarious situation of women seeking services at the MDF.
Article L1121-1 of the Public Health Code (CSP) and Decree No. 2016-1537 of November 16, 2016, stipulate that biomedical research must protect vulnerable individuals, including pregnant women, but authorize clinical trials if the benefits outweigh the risks.
Note: Patients who are not covered by social security will be recruited in accordance with Article L1121-8-1 of the Public Health Code*
- Individuals who are not enrolled in a social security program or who are not beneficiaries of such a program may be recruited to participate in non-interventional research.
- As an exception, the Human Subjects Protection Committee may authorize a person who is not enrolled in or a beneficiary of a social security system to participate in research referred to in paragraphs 1 or 2 of Article L. 1121-1. This authorization must be justified.
Exclusion Criteria:
- All persons under guardianship or conservatorship
- All persons incapable of giving consent
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in quality of life
기간: Baseline
|
Difference in quality of life between initial care and at 6 months, measured using the WHOQoL-BREF self-report questionnaire.
The WHOQOL-BREF is a self-administered questionnaire comprising 26 questions on the individual's perceptions of their health and well-being over the previous two weeks.
Responses to questions are on a 1-5 Likert scale where 1 represents "disagree" or "not at all" and 5 represents "completely agree" or "extremely"
|
Baseline
|
|
Change in quality of life
기간: At 6 months
|
Difference in quality of life between initial care and at 6 months, measured using the WHOQoL-BREF self-report questionnaire.
The WHOQOL-BREF is a self-administered questionnaire comprising 26 questions on the individual's perceptions of their health and well-being over the previous two weeks.
Responses to questions are on a 1-5 Likert scale where 1 represents "disagree" or "not at all" and 5 represents "completely agree" or "extremely"
|
At 6 months
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Post-traumatic stress at 0, 3, and 6 months using the PCL-5 questionnaire.
기간: Baseline
|
The PCL-5 is a 20-item self-report questionnaire that maps directly to the DSM-5 criteria for Post Traumatic Shock Disorder.
Each item asks how much the respondent has been bothered by a specific PTSD symptom over the past month, scored from 0 ("not at all") to 4 ("extremely").
A total symptom severity score (range - 0-80) can be obtained by summing the scores for each of the 20 items.
A PCL-5 cutoff score of 31-33 is indicative of probable Post Traumatic Shock Disorder.
|
Baseline
|
|
Post-traumatic stress at 0, 3, and 6 months using the PCL-5 questionnaire.
기간: At 3 months
|
The PCL-5 is a 20-item self-report questionnaire that maps directly to the DSM-5 criteria for Post Traumatic Shock Disorder.
Each item asks how much the respondent has been bothered by a specific PTSD symptom over the past month, scored from 0 ("not at all") to 4 ("extremely").
A total symptom severity score (range - 0-80) can be obtained by summing the scores for each of the 20 items.
A PCL-5 cutoff score of 31-33 is indicative of probable Post Traumatic Shock Disorder.
|
At 3 months
|
|
Post-traumatic stress at 0, 3, and 6 months using the PCL-5 questionnaire.
기간: At 6 months
|
The PCL-5 is a 20-item self-report questionnaire that maps directly to the DSM-5 criteria for Post Traumatic Shock Disorder.
Each item asks how much the respondent has been bothered by a specific PTSD symptom over the past month, scored from 0 ("not at all") to 4 ("extremely").
A total symptom severity score (range - 0-80) can be obtained by summing the scores for each of the 20 items.
A PCL-5 cutoff score of 31-33 is indicative of probable Post Traumatic Shock Disorder.
|
At 6 months
|
|
Types and frequencies of various forms of vulnerability and violence against women
기간: Baseline
|
Types and frequencies of various forms of vulnerability and violence endured by the women will be recorded.
|
Baseline
|
|
Types and frequencies of various forms of vulnerability and violence against women
기간: At 3 months
|
Types and frequencies of various forms of vulnerability and violence endured by the women will be recorded.
|
At 3 months
|
|
Types and frequencies of various forms of vulnerability and violence against women
기간: At 6 months
|
Types and frequencies of various forms of vulnerability and violence endured by the women will be recorded.
|
At 6 months
|
|
Types of treatments and care pathways used, and assessment of patient adherence
기간: Baseline
|
Types of treatments and care pathways used, and patient adherence to these treatments will be recorded.
|
Baseline
|
|
Types of treatments and care pathways used, and assessment of patient adherence
기간: At 3 months
|
Types of treatments and care pathways used, and patient adherence to these treatments will be recorded.
|
At 3 months
|
|
Types of treatments and care pathways used, and assessment of patient adherence
기간: At 6 months
|
Types of treatments and care pathways used, and patient adherence to these treatments will be recorded.
|
At 6 months
|
|
Change in quality of life at 3 months
기간: Baseline
|
Difference in quality of life between baseline and 3 months, as measured by the WHOQoL-BREF self-report questionnaire.
The WHOQOL-BREF is a self-administered questionnaire comprising 26 questions on the individual's perceptions of their health and well-being over the previous two weeks.
Responses to questions are on a 1-5 Likert scale where 1 represents "disagree" or "not at all" and 5 represents "completely agree" or "extremely"
|
Baseline
|
|
Change in quality of life at 3 months
기간: At 3 months
|
Difference in quality of life between baseline and 3 months, as measured by the WHOQoL-BREF self-report questionnaire.
The WHOQOL-BREF is a self-administered questionnaire comprising 26 questions on the individual's perceptions of their health and well-being over the previous two weeks.
Responses to questions are on a 1-5 Likert scale where 1 represents "disagree" or "not at all" and 5 represents "completely agree" or "extremely"
|
At 3 months
|
|
Change in sleep quality at 3 and 6 months compared to baseline.
기간: Baseline
|
The Pittsburgh Sleep Quality Index questionnaire measures improvements in sleep quality.
It has 19 self-rated questions and 5 questions rated by a bed partner (but only the self-rated questions count) and assesses 7 components of sleep: Subjective Sleep Quality: individual perception of sleep quality, Sleep Latency: how long it takes to fall asleep, Sleep Duration: total hours of sleep per night, Habitual Sleep Efficiency: ratio of hours slept to hours spent in bed, Sleep Disturbances: frequency of problems disrupting sleep (e.g.
waking during the night), Use of Sleep Medication: frequency of taking medications to help sleep, Daytime Dysfunction: difficulties staying awake or maintaining enthusiasm during the day due to sleep issues.
Each item is scored from 0 (no difficulty) to 3 (severe difficulty).
The sum of the 7 scores produces a global score of 0 to 2. Higher scores indicate poorer sleep quality.
A global score over 5 is used to identify individuals with poor sleep quality.
|
Baseline
|
|
Change in sleep quality at 3 and 6 months compared to baseline.
기간: At 3 months
|
The Pittsburgh Sleep Quality Index questionnaire measures improvements in sleep quality.
It has 19 self-rated questions and 5 questions rated by a bed partner (but only the self-rated questions count) and assesses 7 components of sleep: Subjective Sleep Quality: individual perception of sleep quality, Sleep Latency: how long it takes to fall asleep, Sleep Duration: total hours of sleep per night, Habitual Sleep Efficiency: ratio of hours slept to hours spent in bed, Sleep Disturbances: frequency of problems disrupting sleep (e.g.
waking during the night), Use of Sleep Medication: frequency of taking medications to help sleep, Daytime Dysfunction: difficulties staying awake or maintaining enthusiasm during the day due to sleep issues.
Each item is scored from 0 (no difficulty) to 3 (severe difficulty).
The sum of the 7 scores produces a global score of 0 to 2. Higher scores indicate poorer sleep quality.
A global score over 5 is used to identify individuals with poor sleep quality.
|
At 3 months
|
|
Change in sleep quality at 3 and 6 months compared to baseline.
기간: At 6 months
|
The Pittsburgh Sleep Quality Index questionnaire measures improvements in sleep quality.
It has 19 self-rated questions and 5 questions rated by a bed partner (but only the self-rated questions count) and assesses 7 components of sleep: Subjective Sleep Quality: individual perception of sleep quality, Sleep Latency: how long it takes to fall asleep, Sleep Duration: total hours of sleep per night, Habitual Sleep Efficiency: ratio of hours slept to hours spent in bed, Sleep Disturbances: frequency of problems disrupting sleep (e.g.
waking during the night), Use of Sleep Medication: frequency of taking medications to help sleep, Daytime Dysfunction: difficulties staying awake or maintaining enthusiasm during the day due to sleep issues.
Each item is scored from 0 (no difficulty) to 3 (severe difficulty).
The sum of the 7 scores produces a global score of 0 to 2. Higher scores indicate poorer sleep quality.
A global score over 5 is used to identify individuals with poor sleep quality.
|
At 6 months
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- APITHEM/2025/SR-01
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .